IP Library Granted Patent US 8,679,783
Granted Patent B2
US 8,679,783 · App. 13/404,747 · Granted Mar 25, 2014

Recombinant factor X with no glycosylation and method for preparing the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,783
App. No.
13/404,747
Granted
Mar 25, 2014
Kind
B2
Abstract

A Factor X (hereinafter referred to as “FX”) with a high activity is provided. The present invention relates to a method for efficiently preparing a recombinant, two-chain FX which comprises intervening glycosylation at such an amino acid sequence that is essential for glycosylation in FX to thereby allow for expression of a recombinant FX with no glycosylation, and the recombinant FX with no glycosylation obtained by said method.

Claims (18)

1. An isolated or purified polynucleotide that encodes a modified Factor X polypeptide in which an Asn residue at position 181 and/or 191 has been substituted with an amino acid residue other than Asn, and wherein positions 181 and 191 correspond to positions 181 and 191 in the amino acid sequence of SEQ ID NO: 1.

2. An isolated or purified polynucleotide that encodes a modified Factor X polypeptide in which a Thr residue at position 159, 183, 193 and/or 443 has been substituted with an amino acid residue other than Thr or Ser, and wherein positions 159, 183, 193 and 443 correspond to positions 159, 183, 193 and 443 in the amino acid sequence of SEQ ID NO: 1.

3. A vector that comprises the polynucleotide sequence of claim 1 .

4. The vector of claim 3 that is an expression vector.

5. A host cell comprising the vector of claim 3 .

6. The host cell of claim 5 that is glycosylation-deficient.

7. A method for making a two-chain, recombinant Factor X polypeptide comprising culturing the host cell of claim 5 under conditions suitable for expression of recombinant Factor X polypeptide, and

recovering said recombinant Factor X polypeptide.

8. The method of claim 7 that comprises recovering a recombinant Factor X polypeptide having a higher specific activity than that expressed by an otherwise identical host cell expressing an otherwise identical recombinant Factor X polypeptide in which the asparagine-type glycosylation site was not modified.

9. The method of claim 7 that comprises recovering a recombinant Factor X polypeptide in a greater amount than the amount expressed by an otherwise identical host cell expressing recombinant Factor X polypeptide in which the asparagine-type glycosylation site was not modified.

10. A vector that comprises the polynucleotide sequence of claim 2 .

11. The vector of claim 10 that is an expression vector.

12. A host cell comprising the vector of claim 10 .

13. The host cell of claim 12 that is glycosylation-deficient.

14. A method for making a two-chain, recombinant Factor X polypeptide comprising culturing the host cell of claim 12 under conditions suitable for expression of recombinant Factor X polypeptide, and

recovering said recombinant Factor X polypeptide.

15. The method of claim 14 that comprises recovering a recombinant Factor X polypeptide having a higher specific activity than that expressed by an otherwise identical host cell expressing an otherwise identical recombinant Factor X polypeptide in which the asparagine-type glycosylation site was not modified.

16. The method of claim 14 that comprises recovering a recombinant Factor X polypeptide in a greater amount than the amount expressed by an otherwise identical host cell expressing recombinant Factor X polypeptide in which the asparagine-type glycosylation site was not modified.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2020
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: KM BIOLOGICS CO., LTD.
Reel/Frame 051520/0971 →
CHANGE OF ADDRESS OF ASSIGNEE Recorded Apr 15, 2019
From: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 050169/0778 →
CHANGE OF NAME Recorded Jan 16, 2013
From: JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
To: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
Reel/Frame 029636/0944 →